In 85% of MG patients, pathogenetic Abs mainly target the muscle AChRs, while in some cases, Abs targeting muscle-specific kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4) can be detected. The gene discussed is MUSK; the disease is myasthenia gravis.